Establishment Labs Holdings Inc. (NASDAQ:ESTA) Receives Consensus Rating of “Moderate Buy” from Brokerages

Shares of Establishment Labs Holdings Inc. (NASDAQ:ESTA) have been assigned a consensus rating of “Moderate Buy” from the eight brokerages that are covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, one has given a hold rating and six have given a buy rating to the company. The average twelve-month price target among brokerages that have issued ratings on the stock in the last year is $78.8571.

Several equities analysts have issued reports on ESTA shares. Needham & Company LLC restated a “buy” rating and set a $84.00 target price on shares of Establishment Labs in a research note on Monday, January 12th. Mizuho increased their price objective on shares of Establishment Labs from $85.00 to $90.00 and gave the company an “outperform” rating in a research report on Wednesday, December 17th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Establishment Labs in a research report on Monday, December 29th. Wall Street Zen raised Establishment Labs from a “sell” rating to a “hold” rating in a report on Sunday, October 19th. Finally, JPMorgan Chase & Co. raised their price target on Establishment Labs from $71.00 to $80.00 and gave the stock an “overweight” rating in a research note on Wednesday, December 17th.

Institutional Investors Weigh In On Establishment Labs

Hedge funds and other institutional investors have recently made changes to their positions in the business. Quarry LP purchased a new position in shares of Establishment Labs in the third quarter worth approximately $34,000. State of Wyoming purchased a new position in shares of Establishment Labs during the 3rd quarter worth $71,000. Osaic Holdings Inc. grew its position in shares of Establishment Labs by 900.0% during the 2nd quarter. Osaic Holdings Inc. now owns 2,000 shares of the company’s stock valued at $85,000 after acquiring an additional 1,800 shares during the period. CWM LLC increased its stake in shares of Establishment Labs by 45.9% in the 2nd quarter. CWM LLC now owns 2,182 shares of the company’s stock worth $93,000 after purchasing an additional 686 shares in the last quarter. Finally, Truist Financial Corp bought a new position in Establishment Labs in the 4th quarter worth $200,000. Hedge funds and other institutional investors own 72.91% of the company’s stock.

Establishment Labs Stock Performance

ESTA stock opened at $68.79 on Friday. The stock has a market capitalization of $2.00 billion, a PE ratio of -24.22 and a beta of 0.99. Establishment Labs has a 12-month low of $26.56 and a 12-month high of $78.24. The company has a current ratio of 3.33, a quick ratio of 2.10 and a debt-to-equity ratio of 15.06. The stock’s 50 day simple moving average is $70.11 and its 200 day simple moving average is $54.82.

Establishment Labs (NASDAQ:ESTA) last posted its earnings results on Wednesday, November 5th. The company reported ($0.38) EPS for the quarter, topping analysts’ consensus estimates of ($0.54) by $0.16. The business had revenue of $53.78 million during the quarter, compared to analyst estimates of $52.28 million. Establishment Labs had a negative return on equity of 235.45% and a negative net margin of 43.45%.The company’s quarterly revenue was up 33.8% compared to the same quarter last year. During the same quarter last year, the company earned ($0.59) EPS. As a group, research analysts forecast that Establishment Labs will post -2.41 earnings per share for the current fiscal year.

Establishment Labs Company Profile

Establishment Labs Holdings Inc is a global medical technology company specializing in the design, development and manufacture of silicone gel breast implants for aesthetic and reconstructive surgery. The company’s proprietary portfolio is built around patient-focused safety, customization and innovation, offering solutions intended to enhance surgical outcomes and support clinical traceability.

The company’s flagship products fall under the Motiva® brand, which includes a range of ergonomic and round breast implants featuring SilkSurface® texturing and an embedded Q Inside® Safety microtransponder for unique implant identification.